H HARBINGER HEALTH
Live / Registered — Registered (as of 16 Sept 2025)
What this means for you
Registered since 16 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97617580
- Registration number
- 7950484
- Mark type
- Design + words
- Filed
- 03 Oct 2022
- Published for opposition
- 15 Aug 2023
- Registered
- 16 Sept 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer; pharmaceutical preparations comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
- Class 044 — Medical, beauty and agricultural services: Medical diagnostic services for use in the treatment and diagnosis of cancer
Owner
- Harbinger Health, Inc., Cambridge, MA, US
- Harbinger Health, Inc., Cambridge, MA, US
- Harbinger Health, Inc., Cambridge, MA, US
Prosecution history
- 16 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 27 Aug 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Aug 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Apr 2025 — USE AMENDMENT FILED
- 03 Aug 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 10 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Oct 2024 — SOU EXTENSION 2 GRANTED
- 10 Oct 2024 — SOU EXTENSION 2 FILED
- 10 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2024 — SOU EXTENSION 1 GRANTED
- 10 Apr 2024 — SOU EXTENSION 1 FILED